Literature DB >> 3740996

Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis.

M Laakso, O Mutru, H Isomäki, K Koota.   

Abstract

Patients with rheumatoid arthritis (RA), 500 men and 500 women, aged 40 years and over, together with a control population matched by age and sex, were observed over a 10 year period. The overall mortality was significantly higher in both men and women with rheumatoid arthritis than in the controls due to an excess mortality from infections and cardiovascular and renal diseases. During the follow up 31 patients with RA (12 male, 19 female) and one male control subject died from amyloidosis and 42 RA patients (19 male, 23 female) and one male control from renal diseases. The most important causes of renal deaths were chronic nephritis and renal infections.

Entities:  

Mesh:

Year:  1986        PMID: 3740996      PMCID: PMC1001964          DOI: 10.1136/ard.45.8.663

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  Amyloidosis in rheumatoid arthritis.

Authors:  G A MISSEN; J D TAYLOR
Journal:  J Pathol Bacteriol       Date:  1956-01

2.  Survivorship and death in rheumatoid arthritis.

Authors:  J Uddin; A S Kraus; H G Kelly
Journal:  Arthritis Rheum       Date:  1970 Mar-Apr

3.  Gold nephropathy. A clinical and pathologic study.

Authors:  D S Silverberg; E G Kidd; T K Shnitka; R A Ulan
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

4.  Infection in rheumatoid arthritis.

Authors:  J Baum
Journal:  Arthritis Rheum       Date:  1971 Jan-Feb

5.  Renal disease in rheumatoid arthritis.

Authors:  R Friedman; G R Gallo; J N Buxbaum
Journal:  Arthritis Rheum       Date:  1980-06

6.  Death rate and causes of death in patients with rheumatoid arthritis.

Authors:  H A Isomäki; O Mutru; K Koota
Journal:  Scand J Rheumatol       Date:  1975       Impact factor: 3.641

7.  Cause of death in rheumatoid arthritis.

Authors:  P Prior; D P Symmons; D L Scott; R Brown; C F Hawkins
Journal:  Br J Rheumatol       Date:  1984-05

8.  Increased mortality in rheumatoid arthritis.

Authors:  P Allebeck
Journal:  Scand J Rheumatol       Date:  1982       Impact factor: 3.641

9.  Death rate and causes of death in RA patients during a period of five years.

Authors:  K Koota; H Isomäki; O Mutru
Journal:  Scand J Rheumatol       Date:  1977       Impact factor: 3.641

10.  Proteinuria in rheumatoid arthritis--drug-induced or amyloid?

Authors:  B E Bourke; D F Woodrow; J T Scott
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

View more
  13 in total

1.  Where has secondary amyloid gone?

Authors:  B P Hazenberg; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

Review 2.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

3.  Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis.

Authors:  T Yamada; Y Okuda; K Takasugi; K Itoh; J Igari
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

4.  Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy.

Authors:  M Nakano; M Ueno; S Nishi; S Suzuki; H Hasegawa; T Watanabe; T Kuroda; S Ito; M Arakawa
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

Review 5.  Management of co-morbidities and general medical conditions in patients with rheumatoid arthritis.

Authors:  Molly D Magnano; Mark C Genovese
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

Review 6.  Aspirin, paracetamol and non-steroidal anti-inflammatory drugs. A comparative review of side effects.

Authors:  P D Fowler
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

Review 7.  [Prognosis and therapy of inflammatory rheumatic diseases : Impact of renal manifestations].

Authors:  M Zänker; C D Cohen; H D Rupprecht
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

8.  Membranous glomerulonephritis in rheumatoid arthritis unrelated to gold, D-penicillamine or other connective tissue disease.

Authors:  L P Zarza; E N Sanchez; P A Acin; J M Ara; J G Baños
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

9.  Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies.

Authors:  M Boers; A M Croonen; B A Dijkmans; F C Breedveld; F Eulderink; A Cats; J J Weening
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

10.  Development of reduced kidney function in rheumatoid arthritis.

Authors:  LaTonya J Hickson; Cynthia S Crowson; Sherine E Gabriel; James T McCarthy; Eric L Matteson
Journal:  Am J Kidney Dis       Date:  2013-10-04       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.